In-flight cardiac arrest and in-flight cardiopulmonary resuscitation during commercial air travel: consensus statement and supplementary treatment guideline from the German Society of Aerospace Medicine (DGLRM)
Jochen Hinkelbein,Lennert Böhm,Stefan Braunecker,Harald V Genzwürker,Steffen Kalina,Fabrizio Cirillo,Matthieu Komorowski,Andreas Hohn,Jörg Siedenburg,Michael Bernhard,Ilse Janicke,Christoph Adler,Stefanie Jansen,Eckard Glaser,Pawel Krawczyk,Mirko Miesen,Janusz Andres,Edoardo De Robertis,Christopher Neuhaus
DOI: https://doi.org/10.1007/s11739-018-1856-4
Abstract:By the end of the year 2016, approximately 3 billion people worldwide travelled by commercial air transport. Between 1 out of 14,000 and 1 out of 50,000 passengers will experience acute medical problems/emergencies during a flight (i.e., in-flight medical emergency). Cardiac arrest accounts for 0.3% of all in-flight medical emergencies. So far, no specific guideline exists for the management and treatment of in-flight cardiac arrest (IFCA). A task force with clinical and investigational expertise in aviation, aviation medicine, and emergency medicine was created to develop a consensus based on scientific evidence and compiled a guideline for the management and treatment of in-flight cardiac arrests. Using the GRADE, RAND, and DELPHI methods, a systematic literature search was performed in PubMed. Specific recommendations have been developed for the treatment of IFCA. A total of 29 specific recommendations for the treatment and management of in-flight cardiac arrests were generated. The main recommendations included emergency equipments as well as communication of the emergency. Training of the crew is of utmost importance, and should ideally have a focus on CPR in aircraft. The decision for a diversion should be considered very carefully.